SCHEMBL6833221

SCHEMBL6833221

COc1ccc(C=O)c2c(CC(=O)O)coc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
SRC P12931 1/20 0.40
TSHR P16473 2/20 0.38
HPGD P15428 1/20 0.38
GAA P10253 3/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PSMB8 P28062 1/20 0.38
PSMB5 P28074 1/20 0.38
KDM4E B2RXH2 1/20 0.36
ALOX15 P16050 2/20 0.35
MAPT P10636 2/20 0.35
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
ALDH1A1 P00352 3/20 0.35
NFKB1 P19838 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TLR2 O60603 1/20 0.34
ERN1 O75460 1/20 0.34
TLR1 Q15399 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5723151 0.85 ALDH1A1 (0.40) SMN1; SMN2HPGDGAANPSR1KDM4E
SCHEMBL6839353 0.83 ALDH1A1 (0.43) GAAPSMB8PSMB5MAPTALDH1A1
SCHEMBL20588475 0.72 SMN1; SMN2 (0.71) HSD17B10SMN1; SMN2TSHRHPGDGAA
SCHEMBL7948483 0.72 PSMB8 (0.56) HSD17B10SMN1; SMN2HPGDPSMB8PSMB5
Hydrochloric Acid SCHEMBL10671160 0.71 PSMB8 (0.55) HSD17B10SMN1; SMN2HPGDPSMB8PSMB5
SCHEMBL6837723 0.70 PDE4D (0.57)
SCHEMBL10669172 0.70 KDM4E (0.52) HSD17B10SMN1; SMN2TSHRHPGDPSMB5
SCHEMBL5723142 0.68 DPP4 (0.37) SMN1; SMN2TSHRHPGDNPSR1PSMB8
SCHEMBL7371564 0.68 GAA (0.42) HSD17B10SRCTSHRGAAALDH1A1
SCHEMBL12635572 0.67 HSD17B10 (0.64) HSD17B10SMN1; SMN2TSHRHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 HSD17B10 153/4885SMN1; SMN2 1477/4885SRC 1841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.